Many investors believe that a company’s free cash flow (FCF) is one of the more important fundamental metrics in evaluating an equity investment. Some have argued that Wall Street’s focus is on revenue and earnings, which are more easily manipulated through accounting, without direct concern for calculating the actual money that a business is generating.
FCF is operating cash flow minus capital expenditures. FCF is the cash that a company made after paying out the money required to maintain and/or expand the business. Free cash flow enables a company to pursue acquisitions and growth initiatives, among other options. FCF may also allow a company to initiate or increase dividends.
I have screened the market for domestic mid-cap sized companies that are in the healthcare sector. Amongst them, I looked for those that have a current price to FCF of under 10.
Ticker | Company | Industry | Market Cap | P/FCF |
AGP | AMERIGROUP Corporation | Health Care Plans | $3.18 B | 6.95 |
Cephalon Inc. | Biotechnology | $6.08 B | 9.56 | |
Community Health Systems, Inc. | Hospitals | $2.41 B | 6.32 | |
Lifepoint Hospitals Inc. | Hospitals | $2.05 B | 9.51 | |
WellCare Health Plans, Inc. | Health Care Plans | $2.07 B | 6.53 |

